Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Acta Physiol (Oxf) ; 236(3): e13869, 2022 11.
Article in English | MEDLINE | ID: mdl-36002394

ABSTRACT

AIMS: Cardiac contractile dysfunction is prevalent in rheumatoid arthritis (RA), with an increased risk for heart failure. A hallmark of RA has increased levels of peptidyl arginine deaminases (PAD) that convert arginine to citrulline leading to ubiquitous citrullination, including in the heart. We aimed to investigate whether PAD-dependent citrullination in the heart was linked to contractile function in a mouse model of RA during the acute inflammatory phase. METHODS: We used hearts from the collagen-induced arthritis (CIA) mice, with overt arthritis, and control mice to analyze cardiomyocyte Ca2+ handling and fractional shortening, the force-Ca2+ relationship in isolated myofibrils, the levels of PAD, protein post-translational modifications, and Ca2+ handling protein. Then, we used an in vitro model to investigate the role of TNF-α in the PAD-mediated citrullination of proteins in cardiomyocytes. RESULTS: Cardiomyocytes from CIA mice displayed larger Ca2+ transients than controls, whereas cell shortening was similar in the two groups. Myofibrils from CIA hearts required higher [Ca2+ ] to reach 50% of maximum shortening, ie Ca2+ sensitivity was lower. This was associated with increased PAD2 expression and α-actin citrullination. TNF-α increased PAD-mediated citrullination which was blocked by pre-treatment with the PAD inhibitor 2-chloroacetamide. CONCLUSION: Using a mouse RA model we found evidence of impaired cardiac contractile function linked to reduced Ca2+ sensitivity, increased expression of PAD2, and citrullination of α-actin, which was triggered by TNF-α. This provides molecular and physiological evidence for acquired cardiomyopathy and a potential mechanism for RA-associated heart failure.


Subject(s)
Arthritis, Experimental , Arthritis, Rheumatoid , Heart Failure , Animals , Mice , Citrullination , Citrulline/metabolism , Protein-Arginine Deiminases/genetics , Protein-Arginine Deiminases/metabolism , Tumor Necrosis Factor-alpha , Disease Models, Animal , Actins , Hydrolases/metabolism , Arthritis, Rheumatoid/metabolism , Arthritis, Experimental/metabolism , Arginine/pharmacology
2.
Nutrients ; 14(4)2022 Feb 17.
Article in English | MEDLINE | ID: mdl-35215489

ABSTRACT

It is undetermined which blood variables related to iron storage during the first trimester of pregnancy could efficiently predict anemia occurring during the third trimester. Red blood cell count (RBC), hemoglobin concentration, hematocrit, ferritin, iron, and total iron binding capacity (TIBC) were assessed longitudinally during the first, second, and third trimesters of 231 healthy Japanese women. None of the patients had anemia in the first trimester and none used iron supplementation before the second trimester blood test. Anemia was defined as hemoglobin (Hb) < 11 g/dL for the first trimester and Hb < 10.0 g/dL for the third trimester. Forty-seven (20%) women developed anemia in the third trimester. The first trimester RBC, Hb, hematocrit, and ferritin levels were significantly lower in women with third-trimester anemia than those without anemia. The first trimester hemoglobin level exhibited a greater area under the curve of the receiver operating characteristic curve for prediction of the third trimester anemia than other blood variables; the optimal cut-off (12.6 g/dL) of hemoglobin yielded a sensitivity of 83% (39/47). First trimester hemoglobin levels were significantly better predictors of anemia during the third trimester than the indices of iron storage, including serum iron, ferritin, and TIBC levels.


Subject(s)
Anemia, Iron-Deficiency , Anemia , Anemia/diagnosis , Anemia, Iron-Deficiency/diagnosis , Female , Ferritins , Hemoglobins/metabolism , Humans , Iron , Pregnancy , Pregnancy Trimester, Third
3.
Sci Rep ; 12(1): 2581, 2022 02 16.
Article in English | MEDLINE | ID: mdl-35173179

ABSTRACT

Depressive disorders contribute heavily to global disease burden; This is possibly because patients are often treated homogeneously, despite having heterogeneous symptoms with differing underlying neural mechanisms. A novel treatment that can directly influence the neural circuit relevant to an individual patient's subset of symptoms might more precisely and thus effectively aid in the alleviation of their specific symptoms. We tested this hypothesis in a proof-of-concept study using fMRI functional connectivity neurofeedback. We targeted connectivity between the left dorsolateral prefrontal cortex/middle frontal gyrus and the left precuneus/posterior cingulate cortex, because this connection has been well-established as relating to a specific subset of depressive symptoms. Specifically, this connectivity has been shown in a data-driven manner to be less anticorrelated in patients with melancholic depression than in healthy controls. Furthermore, a posterior cingulate dominant state-which results in a loss of this anticorrelation-is expected to specifically relate to an increase in rumination symptoms such as brooding. In line with predictions, we found that, with neurofeedback training, the more a participant normalized this connectivity (restored the anticorrelation), the more related (depressive and brooding symptoms), but not unrelated (trait anxiety), symptoms were reduced. Because these results look promising, this paradigm next needs to be examined with a greater sample size and with better controls. Nonetheless, here we provide preliminary evidence for a correlation between the normalization of a neural network and a reduction in related symptoms. Showing their reproducibility, these results were found in two experiments that took place several years apart by different experimenters. Indicative of its potential clinical utility, effects of this treatment remained one-two months later.Clinical trial registration: Both experiments reported here were registered clinical trials (UMIN000015249, jRCTs052180169).


Subject(s)
Anxiety Disorders/prevention & control , Connectome/methods , Depression/prevention & control , Dorsolateral Prefrontal Cortex/physiology , Nerve Net/physiology , Neurofeedback/methods , Adult , Anxiety Disorders/pathology , Anxiety Disorders/psychology , Brain Mapping , Case-Control Studies , Depression/pathology , Depression/psychology , Female , Humans , Male , Young Adult
4.
J Vis ; 21(8): 24, 2021 08 02.
Article in English | MEDLINE | ID: mdl-34431964

ABSTRACT

Although numerous studies have shown that visual perceptual learning (VPL) occurs as a result of exposure to a visual feature in a task-irrelevant manner, the underlying neural mechanism is poorly understood. In a previous psychophysical study (Watanabe et al., 2002), subjects were repeatedly exposed to a task-irrelevant Sekuler motion display that induced the perception of not only the local motions, but also a global motionmoving in the direction of the spatiotemporal average of the local motion vectors. As a result of this exposure, subjects enhanced their sensitivity only to the local moving directions, suggesting that early visual areas (V1/V2) that process local motions are involved in task-irrelevant VPL. However, this hypothesis has never been tested directly using neuronal recordings. Here, we employed a decoded neurofeedback technique (DecNef) using functional magnetic resonance imaging in human subjects to examine the involvement of early visual areas (V1/V2) in task-irrelevant VPL of local motion within a Sekuler motion display. During the DecNef training, subjects were trained to induce the activity patterns in V1/V2 that were similar to those evoked by the actual presentation of the Sekuler motion display. The DecNef training was conducted with neither the actual presentation of the display nor the subjects' awareness of the purpose of the experiment. After the experiment, subjects reported that they neither perceived nor imagined the trained motion during the DecNef training. As a result of DecNef training, subjects increased their sensitivity to the local motion directions, but not specifically to the global motion direction. Neuronal changes related to DecNef training were confined to V1/V2. These results suggest that V1/V2 are involved in exposure-based task-irrelevant VPL of local motion.


Subject(s)
Motion Perception , Neurofeedback , Humans , Magnetic Resonance Imaging , Motion , Spatial Learning
5.
J Appl Physiol (1985) ; 127(1): 71-80, 2019 07 01.
Article in English | MEDLINE | ID: mdl-31095464

ABSTRACT

Patients with rheumatoid arthritis (RA) frequently suffer from muscle weakness. We examined whether eccentric training prevents skeletal muscle weakness in adjuvant-induced arthritis (AIA) rat, a widely used animal model for RA. AIA was induced in the knees of Wistar rats by injection of complete Freund's adjuvant. To induce eccentric contractions (ECCs), neuromuscular electrical stimulation (45 V) was applied to the plantar flexor muscles simultaneously with forced dorsiflexion of the ankle joint (0-40°) and was given every 6 s. ECC exercise was applied every other day for a total of 11 sessions and consisted of 4 sets of 5 contractions. There was a significant reduction in in vitro maximum Ca2+-activated force in skinned fibers in gastrocnemius muscle from AIA rats. These changes were associated with reduced expression levels of contractile proteins (i.e., myosin and actin), increased levels of inflammation redox stress-related biomarkers (i.e., TNF-α, malondialdehyde-protein adducts, NADPH oxidase 2, and neuronal nitric oxide synthase), and autolyzed active calpain-1 in AIA muscles. ECC training markedly enhanced the steady-state levels of αB-crystallin, a small heat shock protein, and its binding to the myofibrils and prevented the AIA-induced myofibrillar dysfunction, reduction in contractile proteins, and inflammation-oxidative stress insults. Our findings demonstrate that ECC training preserves myofibrillar function without muscle damage in AIA rats, which is at least partially attributable to the protective effect of αB-crystallin on the myofibrils against oxidative stress-mediated protein degeneration. Thus ECC training can be a safe and effective intervention, counteracting the loss of muscle strength in RA patients. NEW & NOTEWORTHY Eccentric contractions (ECCs) are regarded as an effective way to increase muscle strength. No studies, however, assess safety and effectiveness of ECC training on muscle weakness associated with rheumatoid arthritis. Here, we used adjuvant-induced arthritis (AIA) rats to demonstrate that ECC training prevents intrinsic contractile dysfunction without muscle damage in AIA rats, which may be attributed to the protective effect of αB-crystallin on the myofibrils against inflammation-oxidative stress insults.


Subject(s)
Arthritis/metabolism , Muscle Strength/physiology , Muscle, Skeletal/metabolism , Myofibrils/metabolism , Physical Conditioning, Animal/physiology , alpha-Crystallin B Chain/metabolism , Actins/metabolism , Animals , Arthritis/physiopathology , Calcium/metabolism , Disease Models, Animal , Heat-Shock Proteins/metabolism , Male , Muscle Contraction/physiology , Myosins/metabolism , NADPH Oxidases/metabolism , Oxidative Stress/physiology , Rats , Rats, Wistar
6.
Int J Stroke ; 14(9): 915-922, 2019 12.
Article in English | MEDLINE | ID: mdl-31132967

ABSTRACT

BACKGROUND: Branch atheromatous disease (BAD) is distinctive from large and small arterial diseases, which is single subcortical infarction larger than lacunar stroke in the territories of deep perforators without relevant arterial stenosis. BAD meets the current criteria of embolic stroke of undetermined source. We performed an exploratory analysis of BAD in patients recruited to NAVIGATE embolic stroke of undetermined source, a randomized controlled trial to compare rivaroxaban and aspirin in embolic stroke of undetermined source patients. METHODS AND RESULTS: Among 3972 stroke patients in cerebral hemispheres with intracranial arterial imaging, 502 (12.6%) patients met the criteria for BAD. BAD was associated with younger age (years; OR: 0.97, 95% CI: 0.96-0.98), race (Asian; OR: 1.78, 95% CI: 1.44-2.21), region (Eastern Europe; OR: 2.49, 95% CI: 1.87-3.32), and higher National Institute of Health Stroke Scale (OR: 1.17, 95% CI: 1.12-1.22) at randomization. During follow-up, stroke or systemic embolism (2.5%/year vs. 6.2%/year, p = 0.0022), stroke (2.1%/year vs. 6.2%/year, p = 0.0008), and ischemic stroke (2.1%/year vs. 5.9%/year, p = 0.0013) occurred less frequently in BAD than non-BAD patients. There were no differences in annual rates of stroke or systemic embolism (2.5%/year vs. 2.5%/year, HR: 1.01, 95% CI: 0.33-3.14) or major bleeding (1.3%/year vs. 0.8%/year, HR: 1.51, 95% CI: 0.25-9.05) between rivaroxaban and aspirin groups among BAD patients. CONCLUSIONS: BAD was relatively common, especially in Asian and from Eastern Europe among embolic stroke of undetermined source patients. Stroke severity was higher at randomization but recurrence of stroke was fewer in BAD than non-BAD patients. The efficacy and safety of rivaroxaban and aspirin did not differ among BAD patients.


Subject(s)
Factor Xa Inhibitors/therapeutic use , Intracranial Embolism/drug therapy , Plaque, Atherosclerotic/drug therapy , Platelet Aggregation Inhibitors/therapeutic use , Stroke/drug therapy , Aged , Aspirin/therapeutic use , Cerebral Angiography , Computed Tomography Angiography , Female , Hemorrhage/chemically induced , Hemorrhage/epidemiology , Humans , Intracranial Embolism/classification , Intracranial Embolism/diagnostic imaging , Intracranial Hemorrhages/chemically induced , Intracranial Hemorrhages/epidemiology , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male , Middle Aged , Plaque, Atherosclerotic/classification , Plaque, Atherosclerotic/diagnostic imaging , Recurrence , Rivaroxaban/therapeutic use , Secondary Prevention , Stroke/classification , Stroke/diagnostic imaging , Tomography, X-Ray Computed
7.
Int J Neuropsychopharmacol ; 20(10): 769-781, 2017 10 01.
Article in English | MEDLINE | ID: mdl-28977523

ABSTRACT

Psychiatric research has been hampered by an explanatory gap between psychiatric symptoms and their neural underpinnings, which has resulted in poor treatment outcomes. This situation has prompted us to shift from symptom-based diagnosis to data-driven diagnosis, aiming to redefine psychiatric disorders as disorders of neural circuitry. Promising candidates for data-driven diagnosis include resting-state functional connectivity MRI (rs-fcMRI)-based biomarkers. Although biomarkers have been developed with the aim of diagnosing patients and predicting the efficacy of therapy, the focus has shifted to the identification of biomarkers that represent therapeutic targets, which would allow for more personalized treatment approaches. This type of biomarker (i.e., "theranostic biomarker") is expected to elucidate the disease mechanism of psychiatric conditions and to offer an individualized neural circuit-based therapeutic target based on the neural cause of a condition. To this end, researchers have developed rs-fcMRI-based biomarkers and investigated a causal relationship between potential biomarkers and disease-specific behavior using functional MRI (fMRI)-based neurofeedback on functional connectivity. In this review, we introduce a recent approach for creating a theranostic biomarker, which consists mainly of 2 parts: (1) developing an rs-fcMRI-based biomarker that can predict diagnosis and/or symptoms with high accuracy, and (2) the introduction of a proof-of-concept study investigating the relationship between normalizing the biomarker and symptom changes using fMRI-based neurofeedback. In parallel with the introduction of recent studies, we review rs-fcMRI-based biomarker and fMRI-based neurofeedback, focusing on the technological improvements and limitations associated with clinical use.


Subject(s)
Brain/diagnostic imaging , Magnetic Resonance Imaging/methods , Mental Disorders/diagnostic imaging , Neurofeedback/methods , Theranostic Nanomedicine/methods , Animals , Brain/drug effects , Brain/physiopathology , Brain Mapping , Humans , Mental Disorders/physiopathology , Mental Disorders/therapy , Neural Pathways/diagnostic imaging , Neural Pathways/drug effects , Neural Pathways/physiopathology , Psychotropic Drugs/therapeutic use , Rest
8.
PLoS One ; 12(6): e0179925, 2017.
Article in English | MEDLINE | ID: mdl-28636643

ABSTRACT

Skeletal muscle weakness is a prominent feature in patients with rheumatoid arthritis (RA). In this study, we investigated whether neuromuscular electrical stimulation (NMES) training protects against skeletal muscle dysfunction in rats with adjuvant-induced arthritis (AIA). AIA was produced by intraarticular injection of complete Freund's adjuvant into the knees of Wistar rats. For NMES training, dorsiflexor muscles were stimulated via a surface electrode (0.5 ms pulse, 50 Hz, 2 s on/4 s off). NMES training was performed every other day for three weeks and consisted of three sets produced at three min intervals. In each set, the electrical current was set to achieve 60% of the initial maximum isometric torque and the current was progressively increased to maintain this torque; stimulation was stopped when the 60% torque could no longer be maintained. After the intervention period, extensor digitorum longus (EDL) muscles were excised and used for physiological and biochemical analyses. There was a reduction in specific force production (i.e. force per cross-sectional area) in AIA EDL muscles, which was accompanied by aggregation of the myofibrillar proteins actin and desmin. Moreover, the protein expressions of the pro-oxidative enzymes NADPH oxidase, neuronal nitric oxide synthase, p62, and the ratio of the autophagosome marker LC3bII/LC3bI were increased in AIA EDL muscles. NMES training prevented all these AIA-induced alterations. The present data suggest that NMES training prevents AIA-induced skeletal muscle weakness presumably by counteracting the formation of actin and desmin aggregates. Thus, NMES training can be an effective treatment for muscle dysfunction in patients with RA.


Subject(s)
Arthritis, Experimental/therapy , Muscle, Skeletal/metabolism , Actins/metabolism , Animals , Arthritis, Experimental/metabolism , Arthritis, Experimental/physiopathology , Desmin/metabolism , Electric Stimulation Therapy , Male , Microtubule-Associated Proteins/metabolism , Muscle Contraction/physiology , Muscle, Skeletal/drug effects , NADPH Oxidases/metabolism , Nitric Oxide Synthase Type I/metabolism , Peroxynitrous Acid/pharmacology , Rats , Rats, Wistar , Sequestosome-1 Protein/metabolism , Superoxide Dismutase/metabolism , Ubiquitination
9.
J Diabetes Complications ; 31(4): 758-765, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28025025

ABSTRACT

AIMS: Finerenone (BAY 94-8862) is a novel non-steroidal mineralocorticoid receptor antagonist. The aim of this study was to compare the efficacy and safety of seven once-daily oral doses of finerenone (1.25-20mg) and placebo in 96 patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) receiving a RAS blocker. METHODS: ARTS-DN Japan was a multicenter, randomized, double-blind, placebo-controlled, phase 2b study. RESULTS: Analysis of the urinary albumin-to-creatinine ratio (UACR) at day 90 relative to baseline indicated a nominally significant effect of finerenone. The UACR at day 90 relative to baseline for each finerenone treatment group was numerically reduced compared with placebo. No serious adverse events (AEs) or deaths were reported and no patients experienced treatment-emergent AEs resulting in discontinuation of study drug. Small mean increases in serum potassium level were observed in the finerenone treatment groups (0.025-0.167mmol/L) compared with the placebo group (-0.075mmol/L); no patients developed hyperkalemia. CONCLUSION: When given in addition to a RAS inhibitor, finerenone reduced albuminuria without adverse effects on serum potassium levels or renal function in Japanese patients with T2DM and DN.


Subject(s)
Albuminuria/prevention & control , Diabetes Mellitus, Type 2/complications , Diabetic Nephropathies/drug therapy , Kidney/drug effects , Mineralocorticoid Receptor Antagonists/therapeutic use , Naphthyridines/therapeutic use , Renal Insufficiency/drug therapy , Aged , Albuminuria/etiology , Biomarkers/blood , Biomarkers/urine , Diabetic Nephropathies/blood , Diabetic Nephropathies/physiopathology , Diabetic Nephropathies/urine , Disease Progression , Dose-Response Relationship, Drug , Double-Blind Method , Drug Therapy, Combination/adverse effects , Female , Follow-Up Studies , Glomerular Filtration Rate/drug effects , Humans , Japan , Kidney/physiopathology , Male , Middle Aged , Mineralocorticoid Receptor Antagonists/administration & dosage , Mineralocorticoid Receptor Antagonists/adverse effects , Naphthyridines/administration & dosage , Naphthyridines/adverse effects , Renal Insufficiency/complications , Renal Insufficiency/metabolism , Renal Insufficiency/physiopathology , Renin-Angiotensin System/drug effects , Reproducibility of Results
10.
Ann Rheum Dis ; 74(10): 1907-14, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24854355

ABSTRACT

OBJECTIVE: Skeletal muscle weakness is a prominent clinical feature in patients with rheumatoid arthritis (RA), but the underlying mechanism(s) is unknown. Here we investigate the mechanisms behind arthritis-induced skeletal muscle weakness with special focus on the role of nitrosative stress on intracellular Ca(2+) handling and specific force production. METHODS: Nitric oxide synthase (NOS) expression, degree of nitrosative stress and composition of the major intracellular Ca(2+) release channel (ryanodine receptor 1, RyR1) complex were measured in muscle. Changes in cytosolic free Ca(2+) concentration ([Ca(2+)]i) and force production were assessed in single-muscle fibres and isolated myofibrils using atomic force cantilevers. RESULTS: The total neuronal NOS (nNOS) levels were increased in muscles both from collagen-induced arthritis (CIA) mice and patients with RA. The nNOS associated with RyR1 was increased and accompanied by increased [Ca(2+)]i during contractions of muscles from CIA mice. A marker of peroxynitrite-derived nitrosative stress (3-nitrotyrosine, 3-NT) was increased on the RyR1 complex and on actin of muscles from CIA mice. Despite increased [Ca(2+)]i, individual CIA muscle fibres were weaker than in healthy controls, that is, force per cross-sectional area was decreased. Furthermore, force and kinetics were impaired in CIA myofibrils, hence actin and myosin showed decreased ability to interact, which could be a result of increased 3-NT content on actin. CONCLUSIONS: Arthritis-induced muscle weakness is linked to nitrosative modifications of the RyR1 protein complex and actin, which are driven by increased nNOS associated with RyR1 and progressively increasing Ca(2+) activation.


Subject(s)
Actins/metabolism , Arthritis, Experimental/complications , Arthritis, Rheumatoid/complications , Calcium/metabolism , Muscle Weakness/etiology , Aged , Animals , Arthritis, Experimental/metabolism , Arthritis, Rheumatoid/metabolism , Female , Humans , Mice, Inbred DBA , Middle Aged , Muscle Weakness/metabolism , Muscle Weakness/physiopathology , Muscle, Skeletal/metabolism , Muscle, Skeletal/physiopathology , Nitric Oxide Synthase Type I/metabolism , Nitrosation , Ryanodine Receptor Calcium Release Channel/metabolism , Stress, Physiological/physiology
11.
J Clin Neurophysiol ; 31(5): 493-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25271690

ABSTRACT

In the present study, we investigated auditory event-related potentials in adults with Asperger disorder and normal controls using an auditory oddball task and a novelty oddball task. Task performance and the latencies of P300 evoked by both target and novel stimuli in the two tasks did not differ between the two groups. Analysis of variance revealed that there was a significant interaction effect between group and electrode site on the mean amplitude of the P300 evoked by novel stimuli, which indicated that there was an altered distribution of the P300 in persons with Asperger disorder. In contrast, there was no significant interaction effect on the mean P300 amplitude elicited by target stimuli. Considering that P300 comprises two main subcomponents, frontal-central-dominant P3a and parietal-dominant P3b, our results suggested that persons with Asperger disorder have enhanced amplitude of P3a, which indicated activated prefrontal function in this task.


Subject(s)
Asperger Syndrome/physiopathology , Event-Related Potentials, P300/physiology , Acoustic Stimulation , Adult , Analysis of Variance , Decision Making , Electroencephalography , Female , Humans , Male , Psychiatric Status Rating Scales , Reaction Time , Statistics as Topic , Surveys and Questionnaires , Young Adult
12.
Appl Environ Microbiol ; 77(12): 4155-62, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21498752

ABSTRACT

Ralstonia solanacearum is a Gram-negative bacterium and the causative agent of bacterial wilt in many important crops. We treated R. solanacearum with three lytic phages: ϕRSA1, ϕRSB1, and ϕRSL1. Infection with ϕRSA1 and ϕRSB1, either alone or in combination with the other phages, resulted in a rapid decrease in the host bacterial cell density. Cells that were resistant to infection by these phages became evident approximately 30 h after phage addition to the culture. On the other hand, cells infected solely with ϕRSL1 in a batch culture were maintained at a lower cell density (1/3 of control) over a long period. Pretreatment of tomato seedlings with ϕRSL1 drastically limited penetration, growth, and movement of root-inoculated bacterial cells. All ϕRSL1-treated tomato plants showed no symptoms of wilting during the experimental period, whereas all untreated plants had wilted by 18 days postinfection. ϕRSL1 was shown to be relatively stable in soil, especially at higher temperatures (37 to 50°C). Active ϕRSL1 particles were recovered from the roots of treated plants and from soil 4 months postinfection. Based on these observations, we propose an alternative biocontrol method using a unique phage, such as ϕRSL1, instead of a phage cocktail with highly virulent phages. Using this method, ϕRSL1 killed some but not all bacterial cells. The coexistence of bacterial cells and the phage resulted in effective prevention of wilting.


Subject(s)
Bacteriophages/growth & development , Pest Control, Biological/methods , Plant Diseases/prevention & control , Ralstonia solanacearum/growth & development , Ralstonia solanacearum/virology , Bacteriolysis , Solanum lycopersicum/microbiology , Microbial Viability , Plant Diseases/microbiology
13.
Arthritis Rheum ; 60(11): 3280-9, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19877058

ABSTRACT

OBJECTIVE: Progressive muscle weakness is a common feature in patients with rheumatoid arthritis (RA). However, little is known about whether the intrinsic contractile properties of muscle fibers are affected in RA. This study was undertaken to investigate muscle contractility and the myoplasmic free Ca2+ concentration ([Ca2+](i)) in the soleus, a major postural muscle, in mice with collagen-induced arthritis (CIA). METHODS: Muscle contractility and [Ca2+](i) were assessed in whole muscle and intact single-fiber preparations, respectively. The underlying mechanisms of contractile dysfunction were assessed by investigating redox modifications using Western blotting and antibodies against nitric oxide synthase (NOS), superoxide dismutase (SOD), 3-nitrotyrosine (3-NT), carbonyl, malondialdehyde (MDA), and S-nitrosocysteine (SNO-Cys). RESULTS: The tetanic force per cross-sectional area was markedly decreased in the soleus muscle of mice with CIA, and the change was not due to a decrease in the amplitude of [Ca2+](i) transients. The reduction in force production was accompanied by slowing of the twitch contraction and relaxation and a decrease in the maximum shortening velocity. Immunoblot analyses showed a marked increase in neuronal NOS expression but not in inducible or endothelial NOS expression, which, together with the observed decrease in SOD2 expression, favors peroxynitrite formation. These changes were accompanied by increased 3-NT, carbonyl, and MDA adducts content in myofibrillar proteins from the muscles of mice with CIA. Moreover, there was a significant increase in SNO-Cys content in myosin heavy-chain and troponin I myofibrillar proteins from the soleus muscle of mice with CIA. CONCLUSION: These findings show impaired contractile function in the soleus muscle of mice with CIA and suggest that this abnormality is due to peroxynitrite-induced modifications in myofibrillar proteins.


Subject(s)
Arthritis, Experimental/physiopathology , Muscle Contraction/physiology , Muscle, Skeletal/physiopathology , Myofibrils/physiology , Actins/metabolism , Animals , Arthritis, Experimental/metabolism , Arthritis, Rheumatoid/metabolism , Arthritis, Rheumatoid/physiopathology , Body Weight/physiology , Disease Models, Animal , Female , Mice , Mice, Inbred DBA , Myosin Heavy Chains/metabolism , Nitric Oxide Synthase/metabolism , Oxidation-Reduction , Peroxynitrous Acid/metabolism , Superoxide Dismutase/metabolism , Time Factors
14.
Yakugaku Zasshi ; 129(3): 381-4, 2009 Mar.
Article in Japanese | MEDLINE | ID: mdl-19252397

ABSTRACT

To apply human mesenchymal stem cells (hMSC) to regenerative medicines, it is necessary to multiply hMSC in vitro in a short period. In addition, it is desirable that the medium which is used for the hMSC multiplication is not supplemented with the serum, because the addition of the serum has risks of infection. In this study, we cultured hMSC with three kinds of medium used for multiplying hMSC (DMEM, MSCGM, STK2) and compared hMSC proliferation in each medium. As a result, it was confirmed that hMSC proliferation was significantly higher in STK2 medium which is a novel serum-free medium developed for hMSC multiplication. Moreover, we compared the hMSC proliferation in these media under the environment that assumed bone reproduction. When we cultured hMSC in each medium with hydroxyapatite (HAp), the proliferative inhibition by HAp depended on the additive amount, and the degree of the proliferative inhibition was different among the media but the lowest inhibitory effect was observed in STK2 medium.


Subject(s)
Cell Proliferation/drug effects , Culture Media, Serum-Free/pharmacology , Durapatite/pharmacology , Mesenchymal Stem Cells/cytology , Cells, Cultured , Depression, Chemical , Dose-Response Relationship, Drug , Humans , Stimulation, Chemical
15.
Biosci Biotechnol Biochem ; 72(5): 1356-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18460792

ABSTRACT

We identified an effect of theanine on memory functions in a novel object test. Rats were fed theanine for 3 weeks ad libitum, and then they performed the object test. The theanine-fed group performed search behavior for the novel object in the test session. The results suggest that theanine-fed rats showed improved recognition, and that theanine affected learning and memory.


Subject(s)
Behavior, Animal/drug effects , Glutamates/pharmacology , Memory/drug effects , Plant Leaves/chemistry , Tea/chemistry , Animals , Body Weight/drug effects , Drinking/drug effects , Exploratory Behavior/drug effects , Locomotion/drug effects , Male , Rats , Rats, Wistar
16.
Biosci Biotechnol Biochem ; 72(5): 1352-5, 2008 May.
Article in English | MEDLINE | ID: mdl-18460793

ABSTRACT

We identified an effect of gamma-glutamylethylamide (theanine) on feeding in a rat study. Oral theanine suppressed the food intake of rats. The serum glucose level did not differ from the control, but the insulin concentration was reduced and the corticosterone concentration was increased by theanine. We suggest that the effect of theanine on feeding involved hormones.


Subject(s)
Feeding Behavior/drug effects , Glutamates/pharmacology , Plant Leaves/chemistry , Tea/chemistry , Animals , Anti-Obesity Agents/pharmacology , Blood Glucose/metabolism , Corticosterone/blood , Epinephrine/urine , Glucose Tolerance Test , Glutamates/administration & dosage , Insulin/blood , Male , Norepinephrine/urine , Rats , Rats, Wistar
17.
Life Sci ; 81(16): 1247-55, 2007 Sep 29.
Article in English | MEDLINE | ID: mdl-17904164

ABSTRACT

Theanine (r-glutamylethylamide) is one of the major amino acid components in green tea. Recent studies suggest that theanine affects neurotransmission, especially inhibitory neurotransmission. In this study, we investigated whether theanine affects brain development in infant rats, because inhibitory neurotransmission is required for mature brain function. Mother rats were fed theanine ad libitum after confinement. The body weight gain rate of infants was not different from control infants. We detected theanine in the infant serum and measured neurotransmitter concentration and nerve growth factor (NGF) mRNA level in the infant rat brain. Some neurotransmitters, including dopamine, serotonin, glycine and GABA concentration, increased in the infant brain and NGF mRNA level increased in the cerebral cortex and hippocampus. However, these differences were lost by the end of nerve maturity. These results suggest that theanine enhanced synthesis of nerve growth factor and neurotransmitters during a nerve maturing period and promoted central nerve system maturation (CNS). Thus, theanine accelerated maturation. In conclusion, theanine may assist in healthy brain function development.


Subject(s)
Brain , Glutamates/pharmacology , Lactation/metabolism , Nerve Growth Factors/biosynthesis , Neurotransmitter Agents/biosynthesis , RNA, Messenger/biosynthesis , Amino Acids/blood , Amino Acids/metabolism , Animals , Animals, Newborn , Body Weight/drug effects , Brain/drug effects , Brain/growth & development , Brain/metabolism , Female , Glutamates/isolation & purification , Glutamates/pharmacokinetics , Male , Milk/metabolism , Rats , Rats, Wistar , Tea/chemistry
18.
Acta Obstet Gynecol Scand ; 84(3): 255-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15715533

ABSTRACT

BACKGROUND: Several studies have shown that autologous blood storage during pregnancy is relatively safe for mother and fetus. However, the need for reappraisal of autologous blood transfusion in obstetric patients has been proposed. METHODS: We retrospectively reviewed the cases of placenta previa and low-lying placenta among pregnancies at our hospital during an 18-year period, 1985-2002. The utility of autologous blood transfusion program, which started in 1994 for those with placental positional disorders, was evaluated. RESULTS: Of the pregnancies reviewed, there were 158 cases (1.9%) of placenta previa or low-lying placenta. The number of patients transfused with homologous blood decreased from 27.6% (21/76) in the period before implementation of the autologous blood transfusion program to 8.5% (7/82) after its implementation in 1994. In the latter time period, 39.0% (32/82) of patients with placenta previa and low-lying placenta were phlebotomized and had blood stored. Of those, 71.9% (23/32) were reinfused where one patient (3.1%) needed homologous blood as well. The volume of collected blood per phlebotomy was 367 +/- 65 ml, the total volume of collected blood per patient was 803 +/- 350 ml, and the total of estimated blood loss per patient was 1326 +/- 873 ml. The volume of reinfused blood per patient was 578 +/- 326 ml. CONCLUSIONS: The program of autologous blood collection and transfusion in patients with placenta previa resulted in a decrease in homologous blood transfusion. In our program, we recommend starting blood collection and storage at 32 weeks' gestation and phlebotomize 400 ml per week to reach a volume of stored blood of 1200-1500 ml.


Subject(s)
Blood Transfusion, Autologous , Delivery, Obstetric , Hemorrhage/therapy , Placenta Previa/therapy , Adult , Blood Loss, Surgical , Blood Specimen Collection , Cesarean Section/adverse effects , Delivery, Obstetric/adverse effects , Delivery, Obstetric/methods , Female , Hemorrhage/etiology , Humans , Placenta Previa/complications , Postpartum Hemorrhage/therapy , Pregnancy , Pregnancy Outcome , Retrospective Studies , Uterine Hemorrhage/therapy
19.
J Biol Chem ; 278(48): 48259-66, 2003 Nov 28.
Article in English | MEDLINE | ID: mdl-13679380

ABSTRACT

This study attempts to characterize cystatin 10 (Cst10), which we recently identified as a novel protein implicated in endochondral ossification. Expression of Cst10 was specific to cartilage, localized in the cytosol of prehypertrophic and hypertrophic chondrocytes of the mouse growth plate. In the mouse chondrogenic cell line ATDC5, Cst10 expression preceded type X collagen expression and increased in synchrony with maturation. When we compared ATDC5 cells transfected with Cst10 cDNA with cells transfected with a mock vector, hypertrophic maturation and mineralization of chondrocytes were promoted by Cst10 gene overexpression in that type X collagen expression was observed earlier, and alizarin red staining was stronger. On the other hand, type II collagen expression and Alcian blue staining, both of which are markers of the early stage of chondrocyte differentiation, were similar in both cells. Overexpression of the Cst10 gene also caused fragmentation of nuclei, the appearance of annexin V, a change in the mitochondrial membrane potential, and activation of caspases. These results strongly suggest that Cst10 may play an important role in the last steps of the chondrocyte differentiation pathway as an inducer of maturation, followed by apoptosis of chondrocytes.


Subject(s)
Chondrocytes/metabolism , Cystatins/physiology , Alcian Blue/metabolism , Amino Acid Sequence , Animals , Annexin A5/biosynthesis , Anthraquinones/pharmacology , Apoptosis , Blotting, Western , Cartilage/metabolism , Cell Differentiation , Cell Line , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cells, Cultured , Chromosomes/metabolism , Collagen/metabolism , Coloring Agents/pharmacology , Cystatins/chemistry , DNA, Complementary/metabolism , Genetic Vectors , Immunoblotting , Immunohistochemistry , In Situ Hybridization, Fluorescence , Membrane Potentials , Mice , Mice, Transgenic , Microscopy, Fluorescence , Molecular Sequence Data , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Time Factors , Transfection
20.
JSLS ; 7(2): 97-100, 2003.
Article in English | MEDLINE | ID: mdl-12856837

ABSTRACT

OBJECTIVE: Our purpose was to evaluate the efficacy and safety of intraoperative autologous blood transfusion during laparoscopic surgery for hemoperitoneum in benign gynecologic disease. METHODS: The Cell Saver, Haemo Lite 2, an intraoperative autologous blood salvage device, was used in laparoscopic surgery on 18 patients with ectopic pregnancies or ovarian bleeding who had a large hemoperitoneum with/without severe anemia and hypovolemic shock. RESULTS: The blood loss was 1186 +/- 789 mL, and the volume of reinfused processed blood was 661 +/- 405 mL in ectopic pregnancy cases. The blood loss was 716 +/- 219 mL, and the volume of reinfused processed blood was 496 +/- 138 mL in ovarian bleeding. Laparoscopic surgery was performed and homologous blood transfusion was not required in any patient. No adverse reactions or procedural difficulties associated with the autologous blood transfusions occurred. CONCLUSIONS: Intraoperative autologous blood transfusion enabled the performance of laparoscopic surgery for large hemoperitoneum caused by ectopic pregnancies or ovarian bleeding without a homologous blood transfusion.


Subject(s)
Blood Transfusion, Autologous , Hemoperitoneum/therapy , Intraoperative Care , Laparoscopy , Ovarian Diseases/complications , Pregnancy, Ectopic/complications , Adult , Blood Loss, Surgical , Female , Hemoperitoneum/surgery , Hemorrhage/complications , Humans , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL